Company logo

WBA - Walgreens Boots Alliance, Inc.

NASDAQ -> Healthcare -> Pharmaceutical Retailers
Deerfield, United States

WBA price evolution
WBA
(in millions $) 30 Sep 2021 30 Jun 2021 31 Mar 2021 31 Dec 2020
Current assets
Cash $1193 $1345 $1030 $1111
Short term investments
Net receivables $5663 $5153 $4878 $7869
Inventory $8159 $8333 $8541 $11180
Total current assets $15814 $26607 $26084 $21084
Long term investments $6987 $6778 $6202 $6019
Property, plant & equipment $34140 $34324 $34496 $35228
Goodwill & intangible assets $22357 $22928 $22954 $26005
Total noncurrent assets $65471 $65313 $64836 $68083
Total investments $6987 $6778 $6202 $6019
Total assets $81285 $91920 $90920 $89167
Current liabilities
Accounts payable $11136 $11290 $11009 $16212
Deferred revenue
Short long term debt $3564 $10290 $7521 $7680
Total current liabilities $22054 $34475 $31246 $30379
Long term debt $29828 $29820 $33132 $33139
Total noncurrent liabilities $35091 $34539 $37739 $38047
Total debt $33392 $40110 $40653 $40819
Total liabilities $57145 $69014 $68985 $68426
Shareholders' equity
Retained earnings $35121 $34908 $34116 $33495
Other shareholder equity -$2109 -$3180 -$3306 -$3682
Total shareholder equity $23419 $22101 $21112 $20059
(in millions $) 31 Dec 2021 31 Dec 2020 31 Dec 2019 31 Dec 2018
Current assets
Cash $1193 $516 $1023 $785
Short term investments
Net receivables $5663 $7132 $7226 $6573
Inventory $8159 $9451 $9333 $9565
Total current assets $15814 $18073 $18700 $17846
Long term investments $6987 $7338 $6851 $6610
Property, plant & equipment $34140 $35066 $13478 $13911
Goodwill & intangible assets $22357 $26021 $27436 $28697
Total noncurrent assets $65471 $69101 $48898 $50278
Total investments $6987 $7338 $6851 $6610
Total assets $81285 $87174 $67598 $68124
Current liabilities
Accounts payable $11136 $14458 $14341 $13566
Deferred revenue
Short long term debt $3564 $5964 $5738 $1966
Total current liabilities $22054 $27070 $25769 $21667
Long term debt $29828 $34176 $11098 $12431
Total noncurrent liabilities $35091 $38968 $17677 $19768
Total debt $33392 $40140 $16836 $14397
Total liabilities $57145 $66038 $43446 $41435
Shareholders' equity
Retained earnings $35121 $34210 $35815 $33551
Other shareholder equity -$2109 -$3771 -$3897 -$3002
Total shareholder equity $23419 $20637 $23512 $26007
(in millions $) 30 Sep 2021 30 Jun 2021 31 Mar 2021 31 Dec 2020
Revenue
Total revenue $34262 $34030 $32779 $36307
Cost of revenue $26758 $26877 $25998 $29168
Gross Profit $7504 $7153 $6781 $7139
Operating activities
Research & development
Selling, general & administrative $6650 $6116 $6029 $6207
Total operating expenses $7789 $6116 $6029 $6207
Operating income -$285 $1037 $752 $932
Income from continuing operations
EBIT $1301 $1988 $1205 -$367
Income tax expense $586 $246 $42 -$199
Interest expense $88 $545 $137 $140
Net income
Net income $627 $1197 $1026 -$308
Income (for common shares) $627 $1197 $1026 -$308
(in millions $) 31 Dec 2021 31 Dec 2020 31 Dec 2019 31 Dec 2018
Revenue
Total revenue $132509 $139537 $136866 $131537
Cost of revenue $104442 $111520 $106790 $100745
Gross Profit $28067 $28017 $30076 $30792
Operating activities
Research & development
Selling, general & administrative $24586 $27045 $25242 $24569
Total operating expenses $25725 $26704 $25078 $24378
Operating income $2342 $1313 $4998 $6414
Income from continuing operations
EBIT $4114 $1455 $5274 $6638
Income tax expense $667 $360 $588 $998
Interest expense $905 $639 $704 $616
Net income
Net income $2542 $456 $3982 $5024
Income (for common shares) $2542 $456 $3982 $5024
(in millions $) 30 Sep 2021 30 Jun 2021 31 Mar 2021 31 Dec 2020
Net income $627 $1197 $1026 -$308
Operating activities
Depreciation $518 $507 $473 $475
Business acquisitions & disposals $5490 -$80 -$1237 -$77
Stock-based compensation $35 $50 $34 $36
Total cash flows from operations $1245 $1754 $1361 $1195
Investing activities
Capital expenditures -$378 -$309 -$261 -$431
Investments $194 $210 $221 $231
Total cash flows from investing $5413 $15 -$1097 -$259
Financing activities
Dividends paid -$405 -$404 -$403 -$405
Sale and purchase of stock $18 $20 $17 -$106
Net borrowings -$6666 $2841 $229 $156
Total cash flows from financing -$7180 -$1209 -$295 -$352
Effect of exchange rate -$11 -$68 $3 $10
Change in cash and equivalents -$533 $492 -$28 $594
(in millions $) 31 Dec 2021 31 Dec 2020 31 Dec 2019 31 Dec 2018
Net income $2542 $456 $3982 $5024
Operating activities
Depreciation $1973 $1927 $2038 $1770
Business acquisitions & disposals $4096 -$718 -$741 -$4793
Stock-based compensation $155 $137 $119 $130
Total cash flows from operations $5555 $5484 $5594 $8265
Investing activities
Capital expenditures -$1379 -$1374 -$1702 -$1367
Investments $856 $724 $3
Total cash flows from investing $4072 -$1297 -$2307 -$5501
Financing activities
Dividends paid -$1617 -$1747 -$1643 -$1739
Sale and purchase of stock -$51 -$1534 -$3986 -$5054
Net borrowings -$3440 -$1208 $2508 $1596
Total cash flows from financing -$9036 -$4647 -$3047 -$5295
Effect of exchange rate -$66 -$1 -$9 $15
Change in cash and equivalents $525 -$460 $232 -$2516
Fundamentals
Market cap $40.28B
Enterprise value $72.48B
Shares outstanding 865.61M
Revenue $137.38B
EBITDA $6.10B
EBIT $4.13B
Net Income $2.54B
Revenue Q/Q -1.39%
Revenue Y/Y -1.55%
P/E ratio 15.84
EV/Sales 0.53
EV/EBITDA 11.88
EV/EBIT 17.56
P/S ratio 0.29
P/B ratio 1.58
Book/Share 29.49
Cash/Share 1.38
EPS $2.94
ROA 2.88%
ROE 11.73%
Debt/Equity 2.44
Net debt/EBITDA 9.17
Current ratio 0.72
Quick ratio 0.35